Works matching Chalmers, John

Results: 312
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.

    Published in:
    2021
    By:
    • Pinho-Gomes, Ana-Catarina;
    • Azevedo, Luis;
    • Copland, Emma;
    • Canoy, Dexter;
    • Nazarzadeh, Milad;
    • Ramakrishnan, Rema;
    • Berge, Eivind;
    • Sundström, Johan;
    • Kotecha, Dipak;
    • Woodward, Mark;
    • Teo, Koon;
    • Davis, Barry R.;
    • Chalmers, John;
    • Pepine, Carl J.;
    • Rahimi, Kazem;
    • Blood Pressure Lowering Treatment Trialists’ Collaboration
    Publication type:
    journal article
    14
    15

    Declaración de posición del Grupo de la Comisión Lancet de Hipertensión con respecto a la mejora mundial de las normas de exactitud para los dispositivos de medición de la presión arterial.

    Published in:
    Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2020, v. 44, p. 1, doi. 10.26633/RPSP.2020.21
    By:
    • Sharman, James E.;
    • O'Brien, Eoin;
    • Alpert, Bruce;
    • Schutte, Aletta E.;
    • Delles, Christian;
    • Olsen, Michael Hecht;
    • Asmar, Roland;
    • Atkins, Neil;
    • Barbosa, Eduardo;
    • Calhoun, David;
    • Campbell, Norm R. C.;
    • Chalmers, John;
    • Benjamin, Ivor;
    • Jennings, Garry;
    • Laurent, Stéphane;
    • Boutouyrie, Pierre;
    • Lopez-Jaramillo, Patricio;
    • McManus, Richard J.;
    • Mihailidou, Anastasia S.;
    • Ordunez, Pedro
    Publication type:
    Article
    16
    17
    18
    19
    20

    Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.

    Published in:
    European Heart Journal, 2010, v. 31, n. 15, p. 1854, doi. 10.1093/eurheartj/ehq169
    By:
    • Brugts, Jasper Jan;
    • Isaacs, Aaron;
    • Boersma, Eric;
    • van Duijn, Cock M.;
    • Uitterlinden, Andre G.;
    • Remme, Willem;
    • Bertrand, Michel;
    • Ninomiya, Toshiharu;
    • Ceconi, Claudio;
    • Chalmers, John;
    • MacMahon, Stephen;
    • Fox, Kim;
    • Ferrari, Roberto;
    • Witteman, Jacqueline C.M.;
    • Danser, A.H. Jan;
    • Simoons, Maarten L.;
    • de Maat, Moniek P.M.
    Publication type:
    Article
    21

    Amino acid neurotransmitters in hypertension.

    Published in:
    Kidney International Supplement, 1992, n. 37, p. S-2, doi. 10.1111/1523-1755.ep15058409
    By:
    • Arnolda, Leonard;
    • Minson, Jane;
    • Kapoor, Vimal;
    • Pilowsky, Paul;
    • Llewellyn-Smith, Ida;
    • Chalmers, John
    Publication type:
    Article
    22

    Introduction.

    Published in:
    Kidney International Supplement, 1992, n. 37, p. S-1, doi. 10.1111/1523-1755.ep15058402
    By:
    • Elghozi, Jean-Luc;
    • Chalmers, John P.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study.

    Published in:
    Diabetes Care, 2024, v. 47, n. 5, p. 835, doi. 10.2337/dc23-2165
    By:
    • Cahill, Leah E.;
    • Warren, Rachel A.;
    • Carew, Allie S.;
    • Levy, Andrew P.;
    • Sapp, John;
    • Samuel, Michelle;
    • Selvin, Elizabeth;
    • Lavallée, Samantha K.;
    • Poulter, Neil;
    • Marre, Michel;
    • Harrap, Stephen;
    • Mancia, Giuseppe;
    • Harris, Katie;
    • Chalmers, John;
    • Woodward, Mark;
    • Rimm, Eric B.
    Publication type:
    Article
    30
    31

    Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study.

    Published in:
    Diabetes Care, 2023, v. 46, n. 5, p. 967, doi. 10.2337/dc22-1238
    By:
    • Wang, Huan;
    • Cordiner, Ruth L.M.;
    • Huang, Yu;
    • Donnelly, Louise;
    • Hapca, Simona;
    • Collier, Andrew;
    • McKnight, John;
    • Kennon, Brian;
    • Gibb, Fraser;
    • McKeigue, Paul;
    • Wild, Sarah H.;
    • Colhoun, Helen;
    • Chalmers, John;
    • Petrie, John;
    • Sattar, Naveed;
    • MacDonald, Thomas;
    • McCrimmon, Rory J.;
    • Morales, Daniel R.;
    • Pearson, Ewan R.;
    • Blackbourn, Luke
    Publication type:
    Article
    32

    Rising Rates and Widening Socioeconomic Disparities in Diabetic Ketoacidosis in Type 1 Diabetes in Scotland: A Nationwide Retrospective Cohort Observational Study.

    Published in:
    2021
    By:
    • O'Reilly, Joseph E.;
    • Jeyam, Anita;
    • Caparrotta, Thomas M.;
    • Mellor, Joseph;
    • Hohn, Andreas;
    • McKeigue, Paul M.;
    • McGurnaghan, Stuart J.;
    • Blackbourn, Luke A.K.;
    • McCrimmon, Rory;
    • Wild, Sarah H.;
    • Petrie, John R.;
    • McKnight, John A.;
    • Kennon, Brian;
    • Chalmers, John;
    • Phillip, Sam;
    • Leese, Graham;
    • Lindsay, Robert S.;
    • Sattar, Naveed;
    • Gibb, Fraser W.;
    • Colhoun, Helen M.
    Publication type:
    journal article
    33
    34

    Erratum. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications. Diabetes Care 2021;44:390-398.

    Published in:
    2021
    By:
    • Jeyam, Anita;
    • Colhoun, Helen;
    • McGurnaghan, Stuart;
    • Blackbourn, Luke;
    • McDonald, Timothy J.;
    • Palmer, Colin N.A.;
    • McKnight, John A.;
    • Strachan, Mark W.J.;
    • Patrick, Alan W.;
    • Chalmers, John;
    • Lindsay, Robert S.;
    • Petrie, John R.;
    • Thekkepat, Sandeep;
    • Collier, Andrew;
    • MacRury, Sandra;
    • McKeigue, Paul M.;
    • SDRNT1BIO Investigators
    Publication type:
    journal article
    35
    36

    Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.

    Published in:
    2020
    By:
    • Caparrotta, Thomas M.;
    • Blackbourn, Luke A.K.;
    • McGurnaghan, Stuart J.;
    • Chalmers, John;
    • Lindsay, Robert;
    • McCrimmon, Rory;
    • McKnight, John;
    • Wild, Sarah;
    • Petrie, John R.;
    • Philip, Sam;
    • McKeigue, Paul M.;
    • Webb, David J.;
    • Sattar, Naveed;
    • Colhoun, Helen M.;
    • Scottish Diabetes Research Network–Epidemiology Group
    Publication type:
    journal article
    37
    38
    39
    40
    41

    N-Glycan Profile and Kidney Disease in Type 1 Diabetes.

    Published in:
    2018
    By:
    • Bermingham, Mairead L.;
    • Colombo, Marco;
    • McGurnaghan, Stuart J.;
    • Blackbourn, Luke A. K.;
    • Vučković, Frano;
    • Baković, Maja Pučić;
    • Trbojević-Akmačić, Irena;
    • Lauc, Gordan;
    • Agakov, Felix;
    • Agakova, Anna S.;
    • Hayward, Caroline;
    • Klarić, Lucija;
    • Palmer, Colin N. A.;
    • Petrie, John R.;
    • Chalmers, John;
    • Collier, Andrew;
    • Green, Fiona;
    • Lindsay, Robert S.;
    • Macrury, Sandra;
    • McKnight, John A.
    Publication type:
    journal article
    42
    43
    44
    45
    46
    47
    48
    49
    50